Scientists reported androgen receptor (AR) antagonists with efficacy in AR-overexpressing models. These molecules bound to the ligand-binding domain of the AR, promote AR localization to the nucleus, yet potently and selectively down-regulated AR-target genes.
[Proceedings of The National Academy of Sciences of The United States of America]